Total Addressable ED Market (Patients):
By 2025, an estimated 322 million men worldwide will have ED, an increase of 170 million men in 30 years
Affecting ~30 million men in the US
Affecting ~30 million men in the US
1 in 10 men is estimated to have ED at some point in his lifetime
How it works
CUREfilm® Blue (Sildenafil Citrate)
Oral Thin Film:
A Significant PATENT PROTECTED opportunity
Faster Acting
CUREfilm® Blue rapidly dissolves and enters the bloodstream faster than a pill
More Discreet and Spontaneous
Eliminates the issue of timing your meals and pill taking
More convenient
Rapidly dissolves in the mouth without water so it’s easier to take
More effective
By avoiding first pass metabolism less drug is required to achieve the same efficacy
Fewer side effects
No stomach irritations or interactions with the liver, enhancing the safety of the treatment and lowering concerns with repeated usage
Improved Overall Experience
Facilitates frequent usage and loyalty by addressing key unmet needs